Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6X5N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,584
Award facts
- Contract value 100% obligated
- $10,584.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,584.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 300 mg/2 mL pens of Dupixent (a biologic medication used to treat various allergic and inflammatory conditions). The contract, which became effective on January 20, 2026, with an ultimate completion date of January 21, 2026, represents a child delivery order issued under a larger indefinite delivery contract. This award was not set aside for any specific business category and was competitively awarded through the DLA's pharmaceutical procurement processes. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is wholly owned by Cencora, Inc., a major pharmaceutical distribution company.
This delivery order falls under the broader DLA Troop Support Medical indefinite delivery contract (valued at $999,999,999.00 through December 2026) held by Cencora, Inc., which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. The contract vehicle enables delivery of a wide range of pharmaceutical products, medical supplies, specialty medications, vaccines, and related healthcare commodities to support Defense Health Agency programs and other federal medical institutions. The relatively short performance period reflects the urgent nature of pharmaceutical replenishment orders typical of ongoing military medical supply operations.
Quick answers
Who was awarded contract SPE2DR26F6X5N?
SPE2DR26F6X5N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F6X5N worth?
The government has obligated $10,584 on SPE2DR26F6X5N.
Is contract SPE2DR26F6X5N an order under another contract?
Yes. SPE2DR26F6X5N is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6X5N competed?
The extent of competition for SPE2DR26F6X5N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award